103 related articles for article (PubMed ID: 3591815)
1. Prevention and control of influenza. Role of vaccine.
Ruben FL
Am J Med; 1987 Jun; 82(6A):31-4. PubMed ID: 3591815
[TBL] [Abstract][Full Text] [Related]
2. Seasonal influenza vaccines.
Fiore AE; Bridges CB; Cox NJ
Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
[TBL] [Abstract][Full Text] [Related]
3. Vaccines for seasonal and pandemic influenza.
Nichol KL; Treanor JJ
J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
[TBL] [Abstract][Full Text] [Related]
4. Human genetics and responses to influenza vaccination: clinical implications.
Lambkin R; Novelli P; Oxford J; Gelder C
Am J Pharmacogenomics; 2004; 4(5):293-8. PubMed ID: 15462607
[TBL] [Abstract][Full Text] [Related]
5. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.
Glathe H; Lange W
Drugs Aging; 1995 May; 6(5):368-87. PubMed ID: 7647426
[TBL] [Abstract][Full Text] [Related]
8. Novel Platforms for the Development of a Universal Influenza Vaccine.
Kumar A; Meldgaard TS; Bertholet S
Front Immunol; 2018; 9():600. PubMed ID: 29628926
[TBL] [Abstract][Full Text] [Related]
9. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209
[TBL] [Abstract][Full Text] [Related]
10. The road to a more effective influenza vaccine: Up to date studies and future prospects.
Sano K; Ainai A; Suzuki T; Hasegawa H
Vaccine; 2017 Sep; 35(40):5388-5395. PubMed ID: 28866292
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
Treanor JJ; Campbell JD; Zangwill KM; Rowe T; Wolff M
N Engl J Med; 2006 Mar; 354(13):1343-51. PubMed ID: 16571878
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.
Pépin S; Donazzolo Y; Jambrecina A; Salamand C; Saville M
Vaccine; 2013 Nov; 31(47):5572-8. PubMed ID: 24016810
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of influenza vaccination in children: European perspective.
Heikkinen T; Heinonen S
Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481
[TBL] [Abstract][Full Text] [Related]
15. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
16. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
[TBL] [Abstract][Full Text] [Related]
17. Influenza viral neuraminidase: the forgotten antigen.
Johansson BE; Cox MM
Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
[TBL] [Abstract][Full Text] [Related]
18. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
[TBL] [Abstract][Full Text] [Related]
19. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
Munoz FM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Stephens I; Ault K; Winokur P; Petrie CR; Wolff M; Patel SM; Keitel WA
Vaccine; 2018 Dec; 36(52):8054-8061. PubMed ID: 30416018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
